pyruvic acid has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the airways mediated in part by reactive oxygen species (ROS) and reactive nitrogen species (RNS)." | 2.73 | Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease. ( Barton, RW; Bowen, JB; Thrall, RS; Votto, JJ, 2008) |
| "Lung cancer has been the most common death causing cancer in the world for several decades." | 1.42 | Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry. ( Choudhary, MI; Mazhar, S; Musharraf, SG; Rizi, N, 2015) |
| "In subjects with severe COPD, there are alterations in glucose metabolism leading to increased glucose production and faster glucose metabolism by glycolysis and oxidation compared with controls." | 1.38 | Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. ( Bandi, V; Hanania, NA; Hsu, JW; Jahoor, F; Kao, CC; Kheradmand, F, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musharraf, SG | 1 |
| Mazhar, S | 1 |
| Choudhary, MI | 1 |
| Rizi, N | 1 |
| Votto, JJ | 1 |
| Bowen, JB | 1 |
| Barton, RW | 1 |
| Thrall, RS | 1 |
| Kao, CC | 1 |
| Hsu, JW | 1 |
| Bandi, V | 1 |
| Hanania, NA | 1 |
| Kheradmand, F | 1 |
| Jahoor, F | 1 |
1 trial available for pyruvic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Antioxidants; Breath Tests; Double-Blind Method | 2008 |
2 other studies available for pyruvic acid and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.
Topics: Adult; Aged; ATP-Binding Cassette Transporters; Bile Acids and Salts; Case-Control Studies; Citric A | 2015 |
Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.
Topics: Aged; Case-Control Studies; Female; Glucose; Glycolysis; Humans; Male; Middle Aged; Pulmonary Diseas | 2012 |